Show simple item record

dc.contributor.authorWorld Health Organization
dc.coverage.spatialGenevaEN
dc.date.accessioned2014-11-05T09:45:28Z
dc.date.available2014-11-05T09:45:28Z
dc.date.issued2014
dc.identifier.govdocWHO/HIS/KER/GHE/14.2
dc.identifier.urihttps://apps.who.int/iris/handle/10665/137509
dc.language.isoenEN
dc.publisherWorld Health OrganizationEN
dc.subject.meshHemorrhagic Fever, EbolaEN
dc.subject.meshEbola VaccinesEN
dc.subject.meshDrug ApprovalEN
dc.subject.meshEbolavirusEN
dc.subject.meshDisease OutbreaksEN
dc.subject.meshAfrica, WesternEN
dc.subject.meshClinical Trials as TopicEN
dc.subject.meshEthicsEN
dc.subject.meshMeeting Abstract
dc.subject.meshMeeting Abstract
dc.titleEthical issues related to study design for trials on therapeutics for Ebola Virus Disease: WHO Ethics Working Group meeting 20-21 October, summary of discussionEN
dc.typeTechnical documentsEN
dc.subject.meshqualifierdrug therapyEN


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record